Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinobufacini for Premalignant Oral Epithelial Lesions
ChiCTR2300068529Phase 4Not yet recruiting
- Sponsor
- School of Stomatology, Fourth Military Medical University
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cinobufacini in oral dysplasia (OED), sponsored by School of Stomatology, Fourth Military Medical University. Primary endpoints: Pathology evaluation, Numeric rating scales (pain score) and 2 more. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
cinobufacini
03
Conditions
oral dysplasia (OED)
Beyond the preview
Go deeper on ChiCTR2300068529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068529.